- Amarin loses legal fight over heart drug patent; shares sink STAT
- Shares of Amarin Down 68% After Losing a Patent Lawsuit for Vascepa Motley Fool
- IN BRIEF: Amarin plunges after surprise patent ruling on heart drug Reuters
- Amarin Shares Crushed After Judge Rules Heart Drug Patents Invalid: Report TheStreet
- Amarin Plunges After Vascepa Patents Are Invalidated (2) Bloomberg Law
- View Full Coverage on Google News